Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | TYMP | P19971 | 1/20 | 0.50 |
| ▸ | TK1 | P04183 | 3/20 | 0.49 |
| ▸ | TK2 | O00142 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL9298238 | 0.95 | HPGD (0.53) | HPGDMAPK1TYMPTK1TK2 | |
| SCHEMBL17013819 | 0.87 | MAPK1 (0.56) | HPGDMAPK1TYMPTK1 | |
| SCHEMBL11983370 | 0.86 | MAPK1 (0.54) | HPGDMAPK1TYMPTK1 | |
| SCHEMBL5353008 | 0.84 | HPGD (0.55) | HPGDMAPK1TYMPTK1 | |
| SCHEMBL26040009 | 0.84 | HPGD (0.55) | HPGDMAPK1TYMPTK1TK2 | |
| SCHEMBL452185 | 0.84 | MAPK1 (0.53) | HPGDMAPK1TYMPTK1 | |
| SCHEMBL905269 | 0.83 | LMNA (0.49) | HPGDMAPK1TYMPTK1TK2 | |
| SCHEMBL7643586 | 0.83 | MAPK1 (0.51) | HPGDMAPK1TYMPTK1 | |
| SCHEMBL2153004 | 0.83 | TYMP (0.55) | HPGDMAPK1TYMPTK1TK2 | |
| SCHEMBL456976 | 0.83 | KDM4E (0.44) | HPGDMAPK1TYMPTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020170-A | Self-gelling hyaluronic acid-based physical crosslinked hydrogel as well as preparation method and application thereof | 天津大学 | 2025-05-20 | — | — | CN | claimed |
| CN-117659431-A | Modified cobalt-based metal organic framework and application thereof in mercury ion detection | 沈阳药科大学 | 2024-03-08 | — | — | CN | claimed |
| CN-114685605-A | Synthetic method of peptide nucleic acid thymine monomer | 苏州怡彼得生物技术有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-109675056-B | Controlled release system based on base pairing rule and preparation method and application thereof | 南京师范大学 | 2022-03-18 | — | — | CN | claimed |
| US-10421728-B2 | Peptide nucleic acid monomer and a preparation method | AMRITA VISHWA VIDYAPEETHAM (IN) | 2019-09-24 | — | — | US | claimed |
| US-20190262794-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | VIBRANT HOLDINGS, LLC | 2019-08-29 | — | — | US | claimed |
| US-20180354911-A1 | PEPTIDE NUCLEIC ACID MONOMER AND A PREPARATION METHOD | AMRITA VISHWA VIDYAPEETHAM (IN) | 2018-12-13 | — | — | US | claimed |
| EP-3402897-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | Vibrant Holdings, LLC (US) | 2018-11-21 | — | — | EP | claimed |
| WO-2017117292-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | VIBRANT HOLDINGS, LLC (US) | 2017-07-06 | — | — | WO | claimed |
| US-20090298870-A1 | PODOPHYLLOTOXIN DERIVATIVES | Sutter West Bay Hospitals, dba California Pacific Medical Center and Catholic Healthcare West | 2009-12-03 | — | — | US | claimed |
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | AVENTIS PHARMA S.A. (FR) | 2005-08-04 | — | — | US | claimed |
| EP-0792283-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1996015143-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1996-05-23 | — | — | WO | claimed |
| US-5462976-A | Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1995-10-31 | — | — | US | claimed |
| WO-2026101867-A1 | PROCESS FOR PREPARING A MACROCYCLIC DIAMINE, INTERMEDIATES, AND CRYSTALLINE FORMS THEREOF | MERCK SHARP & DOHME LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| CN-119019837-B | Self-repairing material assembled by nucleobase pairs and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-12 | — | — | CN | disclosed |
| US-20260072035-A1 | ENHANCED SPECIFICITY MASS TAG DNA ADDUCTOMICS | UNIV NORTHEASTERN (US) | 2026-03-12 | — | — | US | disclosed |
| WO-1992020703-A1 | THE USE OF NUCLEIC ACID ANALOGUES IN DIAGNOSTICS AND ANALYTICAL PROCEDURES | BUCHARDT OLE (DK) | 1992-11-26 | — | — | WO | disclosed |
| US-4008221-A | BACTERICIDE, ANTIBIOTIC | RICHARDSON-MERRELL INC. (US) | 1977-02-15 | — | — | US | disclosed |
| US-3956288-A | 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives | RICHARDSON-MERRELL INC. (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180354911-A1 | PEPTIDE NUCLEIC ACID MONOMER AND A PREPARATION METHOD | NPPA, ADAR, NSUN3 | HPGD 3598/4885MAPK1 2206/4885TYMP 1410/4885 |
| US-10421728-B2 | Peptide nucleic acid monomer and a preparation method | NPPA, ADAR, NSUN3 | HPGD 3598/4885MAPK1 2206/4885TYMP 1410/4885 |
| US-20260072035-A1 | ENHANCED SPECIFICITY MASS TAG DNA ADDUCTOMICS | DNMT3A, APEX1, CHAMP1 | HPGD 1996/4885MAPK1 1142/4885TYMP 350/4885 |
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | HEXD, CDK5, CHUK | HPGD 114/4885MAPK1 88/4885TYMP 359/4885 |
| US-20090298870-A1 | PODOPHYLLOTOXIN DERIVATIVES | APEH, DAGLA, DPY30 | HPGD 1192/4885MAPK1 4510/4885TYMP 1172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.